PDF
File
Beskrivning
| Land | Finland |
|---|---|
| Lista | Spotlight |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Eevia Health Plc, ("Eevia" or "The Company"), has received a 51 kEUR sales order from a European nutraceutical brand owner with delivery in June 2024 of a bilberry extract.
The customer is a European brand owner headquartered in Sweden. The customer develops and markets effective herbal dietary supplements, as well as cosmetics in over 50.000 pharmacies, health food shops, and other retail outlets across 36 countries, including China and USA.
The purchase order is a repeat order with a sales value to Eevia of c. 51 kEUR for delivery in June. Eevia has the product in stock and can therefore deliver without procurement or production. The product is Feno-Myrtillus® 1, a Bilberry extract standardized for anthocyanins. This is one of the long-term customers Eevia services directly without using a distributor. The business has developed and been stable over the last few years. Eevia is selected due to the high quality and authenticity of the product.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.comorinvestor@eeviahealth.com
Telephone: +358400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forestsnearor above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brandsglobally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts.Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such asbilberry,lingonberry,chaga-mushroom,and pine bark, arewild-harvestedin a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA (https://spotlightstockmarket.com/en/companies/irabout?InstrumentId=XSAT000085FD).
To learn more, please visit www.eeviahealth.comor follow Eevia Health on LinkedIn @EeviaHealth.